AbbVie

Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
Motley Fool
Fri, 11/7/14 - 10:11 am
AbbVie
Gilead Sciences
Enanta
Harvoni
hepatitis C
Who Needs AbbVie? Goldman Adds Shire to Conviction List
WSJ Online
Wed, 11/5/14 - 07:32 pm
Shire
AbbVie
M&A
Investors Could Triple Their Investments in AbbVie
Yahoo/Guru Focus
Sat, 11/1/14 - 12:48 pm
AbbVie
AbbVie CEO: Unlikely to Pursue Another $50 Billion Deal
WSJ Online
Fri, 10/31/14 - 02:02 pm
AbbVie
M&A
Rick Gonzalez
AbbVie Raises Earnings Guidance After Humira Sales Surge
Bloomberg
Fri, 10/31/14 - 08:23 am
AbbVie
earnings
Humira
AbbVie Expected To Post Mixed Q3 Results
Bidness Etc.
Wed, 10/29/14 - 10:16 am
AbbVie
earnings
U.S. law firm says investigating AbbVie over collapsed Shire deal
Yahoo/Reuters
Wed, 10/29/14 - 10:13 am
AbbVie
Shire
M&A
Shire’s Got Big Plans for AbbVie’s Breakup Fee
WSJ Online
Fri, 10/24/14 - 07:05 pm
AbbVie
Shire
M&A
Allergan
AbbVie finally admits it was trying to dodge U.S. taxes
Fortune
Wed, 10/22/14 - 06:57 pm
AbbVie
Shire
tax inversions
M&A
AbbVie's $55B deal for Shire is officially dead. Now what?
Fierce Biotech
Tue, 10/21/14 - 09:26 am
AbbVie
Shire
M&A
AbbVie CEO Gonzalez loses Shire, but wins praise for gusty move
Reuters
Tue, 10/21/14 - 08:16 am
AbbVie
Pharma CEOs
Richard Gonzalez
Shire
M&A
AbbVie says $55 billion acquisition of Shire officially dead
Yahoo/Reuters
Mon, 10/20/14 - 06:36 pm
AbbVie
Shire
M&A
tax inversions
Dept. of Irony: AbbVie Can Take Tax Write-Off for Fees On Busted Shire Deal
WSJ
Sat, 10/18/14 - 10:10 am
AbbVie
Shire
Quote of the Week: AbbVie’s About Face and Management Credibility
WSJ Pharmalot
Fri, 10/17/14 - 10:07 am
AbbVie
Shire
M&A
AbbVie Kills Shire Merger, But Door Opens for Bristol-Myers Squibb?
TheStreet.com
Fri, 10/17/14 - 09:15 am
AbbVie
Shire
M&A
Bristol-Myers Squibb
AbbVie’s Termination Fee Is the Third Largest Ever Paid
WSJ Online
Thu, 10/16/14 - 06:48 pm
AbbVie
Shire
M&A
AbbVie Board Recommends Holders Vote Against Shire Deal
Bloomberg
Thu, 10/16/14 - 07:47 am
AbbVie
Shire
tax inversions
M&A
AbbVie, Shire Have Options Besides Each Other: Real M&A
Bloomberg
Wed, 10/15/14 - 02:54 pm
M&A
AbbVie
Shire
tax inversions
Allergan
Valeant Pharmaceuticals
Should Gilead Sciences, inc. Fear Incoming Competition?
Motley Fool
Wed, 10/15/14 - 02:51 pm
Gilead Sciences
hepatitis C
AbbVie
Bristol-Myers Squibb
Shire says AbbVie should not renege on merger deal
Yahoo/Reuters
Wed, 10/15/14 - 08:07 am
Shire
AbbVie
M&A
tax inversions

Pages